Results 251 to 260 of about 241,744 (291)

Microfluidic Synthesis of Collagen‐Based Microgels for Tissue Engineering Applications

open access: yesNano Select, EarlyView.
We present a droplet microfluidic approach for preparing porous and irregularly shaped microgels of fibrillar collagen and collagen‐glycosaminoglycan (GAG) copolymer in a continuous oil phase at rates of up to 5500 s−1. ABSTRACT To expand the use of collagen‐based biomaterials beyond their current applications in three‐dimensional (3D) cell culture ...
Ehsan Samiei   +2 more
wiley   +1 more source

Copper(II) Inhibition of the SARS‐CoV‐2 Main Protease

open access: yesNatural Sciences, EarlyView.
Molecular Docking of Cu(II) Schiff‐Base Chelates to SARS‐CoV‐2 Mpro. Two distinct Cu(II) chelates (Cu(II)Lp and Cu(II)Lm) are shown docked within the active site pocket of the Mpro, interacting with key residues HIS 41 and CYS 145. ABSTRACT In an analysis of the structural stability of the coronavirus main protease (Mpro), we identified regions of the ...
Roberto A. Garza‐López   +5 more
wiley   +1 more source

Nilotinib attenuates vascular pathology in experimental cerebral malaria. [PDF]

open access: yesBlood Adv
Ortolan LS   +7 more
europepmc   +1 more source

Progress in Aptamer Research and Future Applications

open access: yesChemistryOpen, EarlyView.
This paper mainly describes the screening method of aptamer, the screening difficulties and improvement methods of small molecule aptamer, and the application and treatment of aptamer. It explores the latest progress and application of aptamers, and summarises them, thus indicating some problems that still exist in this field.
Song Liu   +4 more
wiley   +1 more source

The frequency and role of thrombin in human aortas

open access: bronze, 1977
Akira Tanimura   +2 more
openalex   +2 more sources

Hemophilia A: An Ideal Disease for Prenatal Therapy

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy